FDA highlights data-integrity concerns at Pfizer’s India unit; FDA requests removal of all ranitidine products
This week, N-nitrosodimethylamine (NDMA) is back in news as the FDA requests manufacturers to withdraw ranitidine from the mark...
Impressions : 3650
2020 begins with drug price increases in US and mysterious illness in China
This week in Phispers, we have news about pharmaceutical companies ushering in the new year with a hike in US list prices of ov...
Impressions : 2771
After sartans, diabetes drug metformin being tested for cancer causing impurities; FDA’s overseas inspections drop
This week in Phispers, we bring you the major announcements made by Sanofi’s new CEO Paul Hudson at its strategy meet.
...
Impressions : 2745
Astra strikes US$ 6.9 billion oncology deal with Daiichi; Cipla, Jubilant, Indoco’s FDA inspection updates
This week, Phispers brings you news about AstraZeneca’s US$ 6.9 billion deal with Japanese drug major Daiichi Sankyo, whe...
Impressions : 2723
Sanofi and AbbVie CEOs suffer pay cuts, FDA Warning Letters to Pfizer, Jubilant’s Indian operations
This week, Phispers brings you news about two antidepressants — J&J’s esketamine and Allergan’s rapastine...
Impressions : 3608
FDA proposes limits on ‘sartan’ nitrosamine impurities; Text messages add new twist to US generic price fixing litigation
In our final Phispers of 2018, we bring you news on how the big pharmaceutical companies in the US plan to ring in the new year...
Impressions : 5091
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.